Deferasirox in a refractory anemia after other treatment options: case report and literature review.

about

Deferasirox in a refractory anemia after other treatment options: case report and literature review.

Item

http://www.wikidata.org/entity/Q38549248

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Deferasirox in a refractory an ...... report and literature review.

@en

type

Item

label

Deferasirox in a refractory an ...... report and literature review.

@en

prefLabel

Deferasirox in a refractory an ...... report and literature review.

@en

P1476

Deferasirox in a refractory an ...... report and literature review.

@en

P2093

Palma Manduzio

http://www.w3.org/2001/XMLSchema#string

P2860

Deferasirox for managing iron overload in people with myelodysplastic syndrome

International scoring system for evaluating prognosis in myelodysplastic syndromes

Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.

Hepcidin levels and their determinants in different types of myelodysplastic syndromes.

Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging

Revised international prognostic scoring system for myelodysplastic syndromes.

Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes.

Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.

Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes.

P304

361-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1002/CCR3.262

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274458461

http://www.w3.org/2001/XMLSchema#string

P698

26185629

http://www.w3.org/2001/XMLSchema#string

P932

4498843

http://www.w3.org/2001/XMLSchema#string

Deferasirox in a refractory anemia after other treatment options: case report and literature review.

about

Deferasirox in a refractory anemia after other treatment options: case report and literature review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932